Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study Meeting Abstract
| Authors: | Hensley, M. L.; Enserro, D.; Hatcher, H.; Ottevanger, P. B.; Krarup-Hansen, A.; Blay, J. Y.; Fisher, C.; Moxley, K. M.; Lele, S. B.; Lea, J. S.; Tewari, K. S.; Thaker, P. H.; Zivanovic, O.; O'Malley, D. M.; Robison, K.; Miller, D. S. |
| Abstract Title: | Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 295s |
| Language: | English |
| ACCESSION: | WOS:000442916002201 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.5505 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5505 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
